share_log

Further Weakness as NOV (NYSE:NOV) Drops 5.8% This Week, Taking Five-year Losses to 28%

Further Weakness as NOV (NYSE:NOV) Drops 5.8% This Week, Taking Five-year Losses to 28%

進一步的弱勢,紐交所:NOV本週下跌5.8%,五年來的虧損達到28%
Simply Wall St ·  09/12 20:07

The main aim of stock picking is to find the market-beating stocks. But in any portfolio, there will be mixed results between individual stocks. At this point some shareholders may be questioning their investment in NOV Inc. (NYSE:NOV), since the last five years saw the share price fall 31%. We also note that the stock has performed poorly over the last year, with the share price down 22%. Furthermore, it's down 11% in about a quarter. That's not much fun for holders.

選股的主要目的是尋找市場領先的股票。但是在任何投資組合中,個股之間的結果都會好壞參半。目前,一些股東可能會質疑他們對NOV Inc.(紐約證券交易所代碼:NOV)的投資,因爲在過去五年中,股價下跌了31%。我們還注意到,該股去年表現不佳,股價下跌了22%。此外,它在大約一個季度內下降了11%。對於持有者來說,這並不好玩。

Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.

鑑於過去一週對股東來說很艱難,讓我們調查一下基本面,看看我們能學到什麼。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

儘管一些人繼續教導高效市場假說,但事實證明,市場是反應過度的動態系統,投資者並不總是理性的。研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。

NOV became profitable within the last five years. Most would consider that to be a good thing, so it's counter-intuitive to see the share price declining. Other metrics may better explain the share price move.

NOV在過去五年中實現了盈利。大多數人會認爲這是一件好事,因此股價下跌是違反直覺的。其他指標可以更好地解釋股價走勢。

The modest 1.9% dividend yield is unlikely to be guiding the market view of the stock. In contrast to the share price, revenue has actually increased by 1.4% a year in the five year period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.

1.9%的適度股息收益率不太可能指導該股的市場觀點。與股價形成鮮明對比的是,在五年期間,收入實際上每年增長1.4%。因此,看來人們可能必須仔細研究基本面才能理解股價下跌的原因。畢竟,可能有機會。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下圖中看到收入和收入隨時間推移而發生的變化(點擊圖表查看確切值)。

big
NYSE:NOV Earnings and Revenue Growth September 12th 2024
紐約證券交易所:11月收益和收入增長 2024年9月12日

NOV is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. You can see what analysts are predicting for NOV in this interactive graph of future profit estimates.

NOV是一隻知名的股票,有大量分析師報道,這表明未來增長有一定的可見性。您可以在這張未來利潤估計的交互式圖表中看到分析師對NOV的預測。

What About Dividends?

分紅呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, NOV's TSR for the last 5 years was -28%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

在考慮投資回報時,重要的是要考慮股東總回報(TSR)和股價回報之間的差異。儘管股價回報率僅反映股價的變化,但股東總回報率包括股息的價值(假設已進行再投資)以及任何折扣融資或分拆的收益。因此,對於支付豐厚股息的公司來說,股東總回報率通常遠高於股價回報率。碰巧的是,NOV過去5年的股東總回報率爲-28%,超過了前面提到的股價回報率。而且,猜測股息支付在很大程度上解釋了這種分歧是沒有好處的!

A Different Perspective

不同的視角

NOV shareholders are down 21% for the year (even including dividends), but the market itself is up 24%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 5% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for NOV (1 makes us a bit uncomfortable!) that you should be aware of before investing here.

NOV股東今年下跌了21%(甚至包括股息),但市場本身上漲了24%。但是,請記住,即使是最好的股票有時也會在十二個月內表現不如市場。不幸的是,去年的表現可能預示着尚未解決的挑戰,因爲它比過去五年中5%的年化虧損還要糟糕。我們意識到羅斯柴爾德男爵曾說過,投資者應該 「在街頭流血時買入」,但我們警告說,投資者應首先確保他們購買的是高質量的企業。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。例如,我們發現了 2 個 11 月的警告信號(1 個讓我們有點不舒服!)在這裏投資之前,您應該注意這一點。

But note: NOV may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但請注意:NOV可能不是最好的買入股票。因此,來看看這份過去盈利增長(以及進一步增長預測)的有趣公司的免費清單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論